Q4 2025 Holdings
Filed 2026-02-12 | 28 holdings | $467.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $177.2M | 8,166,047 | 37.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $46.5M | 267,000 | 9.9% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $23.6M | 298,682 | 5.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $21.9M | 26,000 | 4.7% |
| Beone Medicines LTD(ONC) | SPONSORED ADS | 07725L102 | $21.1M | 69,312 | 4.5% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $17.5M | 130,000 | 3.8% |
| Pharvaris N V(PHVS) | COM | N69605108 | $15.1M | 542,696 | 3.2% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $14.3M | 780,000 | 3.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $12.9M | 320,000 | 2.8% |
| Celcuity Inc(CELC) | COM | 15102K100 | $12.0M | 120,000 | 2.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $11.3M | 317,372 | 2.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $10.8M | 139,000 | 2.3% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $7.8M | 227,000 | 1.7% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $6.9M | 359,050 | 1.5% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $6.8M | 4,963,756 | 1.5% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $6.2M | 150,000 | 1.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $6.1M | 136,500 | 1.3% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $6.1M | 210,000 | 1.3% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $5.9M | 490,000 | 1.3% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $5.9M | 74,000 | 1.3% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $5.7M | 311,966 | 1.2% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $4.9M | 150,000 | 1.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $4.7M | 308,141 | 1.0% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $4.3M | 127,000 | 0.9% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $4.2M | 350,000 | 0.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.1M | 170,000 | 0.9% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $3.1M | 1,132,815 | 0.7% |
| Harrow Inc(HROW) | COM | 415858109 | $344.5K | 7,031 | 0.1% |